These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14713717)

  • 1. CTLA-4 and tolerance: the biochemical point of view.
    Chikuma S; Bluestone JA
    Immunol Res; 2003; 28(3):241-53. PubMed ID: 14713717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4.
    Tivol EA; Gorski J
    J Immunol; 2002 Aug; 169(4):1852-8. PubMed ID: 12165509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-independent inhibition of T cells by CTLA-4.
    Chikuma S; Abbas AK; Bluestone JA
    J Immunol; 2005 Jul; 175(1):177-81. PubMed ID: 15972645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
    Fife BT; Griffin MD; Abbas AK; Locksley RM; Bluestone JA
    J Clin Invest; 2006 Aug; 116(8):2252-61. PubMed ID: 16886063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
    Pentcheva-Hoang T; Egen JG; Wojnoonski K; Allison JP
    Immunity; 2004 Sep; 21(3):401-13. PubMed ID: 15357951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.
    Darlington PJ; Kirchhof MG; Criado G; Sondhi J; Madrenas J
    J Immunol; 2005 Jul; 175(2):996-1004. PubMed ID: 16002699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4.
    Chikuma S; Imboden JB; Bluestone JA
    J Exp Med; 2003 Jan; 197(1):129-35. PubMed ID: 12515820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation.
    Darlington PJ; Baroja ML; Chau TA; Siu E; Ling V; Carreno BM; Madrenas J
    J Exp Med; 2002 May; 195(10):1337-47. PubMed ID: 12021313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is CTLA-4 a master switch for peripheral T cell tolerance?
    Bluestone JA
    J Immunol; 1997 Mar; 158(5):1989-93. PubMed ID: 9036940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-deficient autoreactive T cells are highly susceptible to suppression by CD4(+)CD25(+) regulatory T cells.
    May KF; Chang X; Zhang H; Lute KD; Zhou P; Kocak E; Zheng P; Liu Y
    J Immunol; 2007 Feb; 178(3):1542-52. PubMed ID: 17237403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell regulation by CD28 and CTLA-4.
    Alegre ML; Frauwirth KA; Thompson CB
    Nat Rev Immunol; 2001 Dec; 1(3):220-8. PubMed ID: 11905831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
    Schwartz JC; Zhang X; Fedorov AA; Nathenson SG; Almo SC
    Nature; 2001 Mar; 410(6828):604-8. PubMed ID: 11279501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.
    Jain N; Nguyen H; Chambers C; Kang J
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1524-8. PubMed ID: 20080649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
    Prud'homme GJ; Chang Y; Li X
    Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4, a negative regulator of T-lymphocyte activation.
    Waterhouse P; Marengère LE; Mittrücker HW; Mak TW
    Immunol Rev; 1996 Oct; 153():183-207. PubMed ID: 9010724
    [No Abstract]   [Full Text] [Related]  

  • 19. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.
    Tivol EA; Boyd SD; McKeon S; Borriello F; Nickerson P; Strom TB; Sharpe AH
    J Immunol; 1997 Jun; 158(11):5091-4. PubMed ID: 9164923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.